World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00531882
Date of registration: 18/09/2007
Primary sponsor: University Hospitals of Cleveland
Public title: Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers
Scientific title: A Pilot Study Evaluating the Effect of Pioglitazone, Simvastatin, and Ibuprofen on Neutrophil Migration in Vivo in Healthy Subjects
Date of first enrolment: September 2007
Target sample size: 10
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT00531882
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label  
Countries of recruitment
United States
Contacts
Name:   Kathleen A Hilliard, BA, CCRC
Address: 
Telephone: 216-844-7489
Email: kathleen.hilliard@case.edu
Affiliation: 
Name:   Kathleen A Hilliard, BA, CCRC
Address: 
Telephone: 216.844.7489
Email: kathleen.hilliard@case.edu
Affiliation: 
Name:   Michael W Konstan, MD
Address: 
Telephone:
Email:
Affiliation:  University Hospitals of Cleveland
Key inclusion & exclusion criteria

Inclusion Criteria:

- = 18 < 50 years of age

- Healthy volunteers must be in general good health as determined by a medical
history.

- Ability to understand and sign the informed consent form

- Ability to adhere to the protocol.

- Willing to use an acceptable form of birth control

Exclusion Criteria:

- History of diabetes requiring insulin

- The use of NSAIDS (ibuprofen) or corticosteroids including inhaled steroids. Nasal
steroids are acceptable.

- The use of statin lowering medications

- Active gingival disease (Active tooth or gum disease)

- Any chronic inflammatory condition that immuno compromises the volunteer as
determined by medical history.

- Pregnant or planning to become pregnant



Age minimum: 18 Years
Age maximum: 50 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Anti Inflammatory Non-Steroidal
Cystic Fibrosis
Neutrophils
Intervention(s)
Drug: Ibuprofen
Drug: Pioglitazone
Drug: Simvastatin
Primary Outcome(s)
Neutrophil delivery to the oral mucosa using a noninvasive mouth wash technique [Time Frame: 3x before treatment, 3x during treatment and 3x post treatment]
Secondary Outcome(s)
Secondary ID(s)
Pilot Healthy Volunteers
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history